Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03562988 · ClinicalTrials.gov registry record · NA
Bioequivalence Study on Vitamin C in Healthy Adults
A NA study, sponsored by Church & Dwight Company.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT03562988: Completed NA study, sponsored by Church & Dwight Company.
NCT03562988 is a NA study that has completed, run by Church & Dwight Company. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03562988, a NA study, has completed, sponsored by Church & Dwight Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The objective of this exploratory pharmacokinetic research study is to demonstrate that both caplets and gummies provide an effective dose of ascorbic acid in healthy adults.
Primary Outcome
Mean Plasma L-ascorbic Acid as Total Area Under the Curve \[AUC(0-24 hours)\]
Interventions
- DIETARY_SUPPLEMENT Vitamin C gummy
- DIETARY_SUPPLEMENT Vitamin C tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2017-12-22 |
| Phase | NA |
What the finished NCT03562988 record still lists
NCT03562988 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Vitamin C gummy is the first listed.
NCT03562988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03562988 about?
NCT03562988 is a clinical study titled "Bioequivalence Study on Vitamin C in Healthy Adults". The objective of this exploratory pharmacokinetic research study is to demonstrate that both caplets and gummies provide an effective dose of ascorbic acid in healthy adults.
What is the current status of trial NCT03562988?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2017-08-01. Estimated completion is 2017-12-22.
What interventions are being tested in trial NCT03562988?
The interventions under investigation include: Vitamin C gummy (DIETARY_SUPPLEMENT), Vitamin C tablet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03562988?
This trial is sponsored by Church & Dwight Company, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03562988's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI